Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,824.05
+36.50 (2.04%)
At close: Jul 13, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 462.58 billion as of July 13, 2026. Its market cap has increased by 34.62% in one year.
Market Cap
462.58B
Enterprise Value
473.31B
Revenue
96.47B
Ranking
n/a
PE Ratio
40.54
Stock Price
1,824.05
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 462.58B, an increase of 14,271.38%. That is a compound annual growth rate of 22.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 462.58B | 28.50% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.04T |
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |